Becker's Spine Review

25 DEVICES & IMPLANTS nologies together and apply predictive analytics across the continuum of care, that's where I think the future is going. With Mobius, the team really under- stands imaging and all the needs for the customer in the imaging space. Q: Surgeons are feeling pres- sure from all sides to deliver quality and control their costs. They are caring for patients in a value-based environment. How do you keep that front of mind when you are developing tech- nologies or working with your surgeons to make sure they have what they need? EM: We now can leverage the size of Stryker and the resources of Stryker while bringing the innovation of the legacy K2M machine inside. By doing that, we can continue to innovate like crazy, but we have the scale of the man- ufacturing facilities that will help us think about cost structure as we are do- ing that, and the ability to think about the continuum: the preoperative plan- ning, imaging, how implants could po- tentially work in the robotic space, and postoperative follow-up. at allows us to collaborate from the cost perspective, because you have more resources to work with. I'm excited to continue to see how we can work with hospital systems. Q: Are there any headwinds you are preparing for heading into next year? EM: We are in an exciting place from my perspective. We have built out a ton of these resources, and there is a great tone from the top. Kevin Lobo, our Chairman and Chief Executive Officer, has asked us what we need in order to build a great spine business. We have K2M and Mobi- us; we are doing the things that need to be done to build out not only the foun- dation but to expand upon that, so that we have a strong spine business. When Stryker has a strong spine business, that rolls into so many other aspects of the company. e spine sales representatives are in the operating room nearly every day, and they play a large role there by having strong relationships with the HCPs in the room. In addition to spinal implants, there is so much other capi- tal. Whether it's instruments, imaging, endoscopy or lights, the spine rep oen helps open the door for our sister divi- sions to introduce these technologies. We need to operate in the environment of our business. We can't impact chang- es in the geopolitical space; we know there is always going to be change. We are always trying to look out ahead and think what will happen there. e larger business of Stryker allows us to pivot if something unexpected happens. I am feeling huge tailwinds as we fin- ish out 2019, because we have done so much to bring these two great organi- zations together. We'll be now looking to 2020 to integrate the Mobius tech- nology. at just adds to the excitement to our field force. Q: When looking at the entire Stryker spine business, where do you see the best place for Stryker to keep growing and developing as a company? EM: Healthcare continues to change. I think Stryker continues to stay focused on being a leader in medical technolo- gy by being a best-in-class collabora- tor. Together with our customers, we are driven to make healthcare better. I do think we are going to see continued changes in the healthcare environment, but we have the ability and resources to respond to those changes. ere is a lot of talk about enabling technologies, and I think processing power is better than in the past. at is starting to accelerate, and as we look to that future, the ability to be a resource for our customers across the entire continuum is exciting. Stryker has the scale and resources to build out an entire solution to care for the patient. Note: A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a partic- ular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular prod- uct before using it in surgery. e information presented is intended to demonstrate the breadth of Stryker prod- uct offerings. A surgeon must always refer to the package insert, product label and/ or instructions for use before using any Stryker product. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Stryker rep- resentative if you have questions about the availability of Stryker products in your area. n 10 devicemakers with highest payouts to physicians, hospitals — Zimmer Biomet is No. 1 By Angie Stewart T he world's biggest medical device companies made more than $542.6 million in general payments to phy- sicians and hospitals in 2018, according to MassDevice's analysis of the Medical Design & Outsourcing Big 100 list and CMS Open Payments data. Ten device companies that made the most general payments to physicians and teaching hospitals in 2018, and the percentage of annual revenue those pay- ments made up: Zimmer Biomet $109.4 million 1.3 percent Medtronic $106.6 million 0.3 percent Stryker $91.8 million 0.7 percent Boston Scientific $82.2 million 0.8 percent Johnson & Johnson $77.7 million 0.3 percent Abbott Labs $33.8 million 0.3 percent Alcon $14 million 0.2 percent Siemens Healthineers $10 million 0.06 percent BD $8.7 million 0.1 percent Royal Philips $8.4 million 0.04 percent n

• Cover